Back

δ1 variant of SARS-COV-2 acquires spike V1176F and yields a highly mutated subvariant in Europe

Yang, X.-J.

2021-10-19 evolutionary biology
10.1101/2021.10.16.463825 bioRxiv
Show abstract

Genomic surveillance of SARS-COV-2 has revealed that in addition to many variants of interests, this virus has yielded four variants of concern, , {beta}, {gamma} and {delta}, as designated by the World Health Organization. {delta} variant has recently become the predominant pandemic driver around the world and yielded four different subvariants ({delta}1, {delta}2, {delta}3 and {delta}4). Among them, {delta}1 has emerged as the key subvariant that drives the pandemic in India, Europe and the USA. A relevant question is whether {delta}1 subvariant continues to evolve and acquires additional mutations. Related to this, this subvariant has acquired spike V1176F, a signature substitution of {gamma} variant, and yielded a new sublineage, {delta}1F. The substitution alters heptad repeat 2 of spike protein and is expected to improve interaction with heptad repeat 1 and enhance virus entry. Moreover, there are {delta}1F sublineages encoding spike N501Y, A783S, Q836E and V1264L. While N501Y is a signature substitution shared by , {beta} and {gamma} variants, V1264L is a key substitution in a {delta}1 sublineage that is a major pandemic driver in Southeast Asia. The Q836E-encoding lineage carries an average of 50 mutations per genome, making it the most mutated variant identified so far. Similar to {delta}1 subvariant, {delta}2 subvariant has also acquired spike V1176F and yielded new sublineages. Together, these results suggest that V1176F is a recurrent spike substitution that is frequently acquired by SARS-COV-2 variants to improve viral fitness. It is thus important to track the evolutionary trajectory of related variants for considering and instituting the most effective public health measures.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
PLOS Pathogens
820 papers in training set
Top 1%
11.6%
2
Vaccines
198 papers in training set
Top 0.2%
10.8%
3
Journal of Biomedical Science
17 papers in training set
Top 0.1%
9.5%
4
Viruses
332 papers in training set
Top 0.7%
6.6%
5
PLOS ONE
5266 papers in training set
Top 29%
5.4%
6
Science Bulletin
21 papers in training set
Top 0.1%
3.9%
7
Journal of Virology
499 papers in training set
Top 2%
3.4%
50% of probability mass above
8
National Science Review
21 papers in training set
Top 0.1%
3.2%
9
Journal of Medical Virology
140 papers in training set
Top 0.8%
3.2%
10
eLife
5828 papers in training set
Top 39%
2.6%
11
Genomics, Proteomics & Bioinformatics
172 papers in training set
Top 0.8%
2.3%
12
Scientific Reports
3612 papers in training set
Top 49%
2.1%
13
mBio
833 papers in training set
Top 7%
2.1%
14
Pathogens
56 papers in training set
Top 0.6%
1.7%
15
Archives of Virology
15 papers in training set
Top 0.2%
1.7%
16
iScience
1154 papers in training set
Top 19%
1.6%
17
Virus Evolution
155 papers in training set
Top 1%
1.3%
18
International Journal of Molecular Sciences
494 papers in training set
Top 10%
1.3%
19
Emerging Microbes & Infections
74 papers in training set
Top 0.8%
1.3%
20
Frontiers in Microbiology
427 papers in training set
Top 7%
1.1%
21
PLOS Genetics
862 papers in training set
Top 10%
1.0%
22
PLOS Computational Biology
1863 papers in training set
Top 19%
1.0%
23
Molecular Biology and Evolution
542 papers in training set
Top 5%
1.0%
24
Computers in Biology and Medicine
128 papers in training set
Top 4%
1.0%
25
Frontiers in Public Health
148 papers in training set
Top 6%
1.0%
26
BMC Genomics
406 papers in training set
Top 9%
0.8%
27
Journal of Molecular Biology
232 papers in training set
Top 4%
0.8%
28
Heliyon
152 papers in training set
Top 8%
0.8%
29
BMC Biology
265 papers in training set
Top 7%
0.6%
30
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 46%
0.6%